Utilization of lipid modifying agents in the Karvina district: A comparison with the Czech Republic, 2002 to 2009
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11160%2F12%3A10124854" target="_blank" >RIV/00216208:11160/12:10124854 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/62157124:16370/12:43870972
Výsledek na webu
<a href="http://www.academicjournals.org/ajpp/PDF/pdf2012/29%20Mar/Bartas%20et%20al.pdf" target="_blank" >http://www.academicjournals.org/ajpp/PDF/pdf2012/29%20Mar/Bartas%20et%20al.pdf</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.5897/AJPP11.887" target="_blank" >10.5897/AJPP11.887</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Utilization of lipid modifying agents in the Karvina district: A comparison with the Czech Republic, 2002 to 2009
Popis výsledku v původním jazyce
The objective of this study was to evaluate the structure and development of consumption of hypolipidemic agents. Data concerning utilization of individual hypolipidemic drugs from 2002 to 2009 were obtained from the State Institute for Drug Control database and General Health Insurance Company, Karvina district database. Utilization of hypolipidemic drugs were stated in DDDs in correspondence with the anatomical therapeutic chemical (ATC) classification, and the costs in CZK. Information on utilizationis expressed in the number of DDD per 1,000 inhabitants per 1 day (DID). The utilization of fibrates slightly decreased, while statins increase from 13.55 DID (2002) to 60.10 DID (2009) was observed. The total utilization of hypolipidemic drugs in DID have been continuously increasing (32.34 DID in 2002, 76.30 DID in 2009). In the compared data from the Karvina district, an increased utilization of fibrates and decreased utilization of statins were observed. The most significant differe
Název v anglickém jazyce
Utilization of lipid modifying agents in the Karvina district: A comparison with the Czech Republic, 2002 to 2009
Popis výsledku anglicky
The objective of this study was to evaluate the structure and development of consumption of hypolipidemic agents. Data concerning utilization of individual hypolipidemic drugs from 2002 to 2009 were obtained from the State Institute for Drug Control database and General Health Insurance Company, Karvina district database. Utilization of hypolipidemic drugs were stated in DDDs in correspondence with the anatomical therapeutic chemical (ATC) classification, and the costs in CZK. Information on utilizationis expressed in the number of DDD per 1,000 inhabitants per 1 day (DID). The utilization of fibrates slightly decreased, while statins increase from 13.55 DID (2002) to 60.10 DID (2009) was observed. The total utilization of hypolipidemic drugs in DID have been continuously increasing (32.34 DID in 2002, 76.30 DID in 2009). In the compared data from the Karvina district, an increased utilization of fibrates and decreased utilization of statins were observed. The most significant differe
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FR - Farmakologie a lékárnická chemie
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2012
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
African Journal of Pharmacy and Pharmacology
ISSN
1996-0816
e-ISSN
—
Svazek periodika
6
Číslo periodika v rámci svazku
12
Stát vydavatele periodika
NG - Nigérijská federativní republika
Počet stran výsledku
10
Strana od-do
924-933
Kód UT WoS článku
000303768400010
EID výsledku v databázi Scopus
—